Principal Financial Group Inc Celldex Therapeutics, Inc. Transaction History

Principal Financial Group Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$32.76 - $42.56 $84,553 - $109,847	-2,581 Reduced 19.62%	10,572 $391,000
Q1 2024 Apr 29, 2024	BUY	$35.22 - $51.88 $42,052 - $61,944	1,194 Added 9.98%	13,153 $552,000
Q4 2023 Feb 07, 2024	SELL	$22.61 - $40.65 $20,100 - $36,137	-889 Reduced 6.92%	11,959 $474,000
Q3 2023 Nov 02, 2023	BUY	$25.45 - $37.46 $38,098 - $56,077	1,497 Added 13.19%	12,848 $353,000
Q2 2023 Aug 07, 2023	SELL	$30.29 - $38.28 $21,081 - $26,642	-696 Reduced 5.78%	11,351 $385,000
Q1 2023 May 09, 2023	BUY	$34.78 - $47.43 $48,483 - $66,117	1,394 Added 13.09%	12,047 $433,000
Q4 2022 Feb 09, 2023	BUY	$27.78 - $45.38 $3,000 - $4,901	108 Added 1.02%	10,653 $474,000
Q3 2022 Nov 09, 2022	BUY	$22.7 - $37.57 $43,288 - $71,645	1,907 Added 22.08%	10,545 $297,000
Q2 2022 Aug 10, 2022	SELL	$20.5 - $37.33 $693,945 - $1.26 Million	-33,851 Reduced 79.67%	8,638 $233,000
Q1 2022 May 09, 2022	SELL	$27.64 - $39.32 $417,750 - $594,282	-15,114 Reduced 26.24%	42,489 $1.45 Million
Q4 2021 Feb 09, 2022	SELL	$35.68 - $56.27 $1.28 Million - $2.02 Million	-35,825 Reduced 38.35%	57,603 $2.23 Million
Q3 2021 Nov 09, 2021	BUY	$28.95 - $55.99 $276,848 - $535,432	9,563 Added 11.4%	93,428 $5.04 Million
Q2 2021 Aug 10, 2021	BUY	$20.71 - $35.37 $1.74 Million - $2.97 Million	83,865 New	83,865 $2.8 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.